Increased GMP Production Capacity: Our collaboration with 3PBIOVIAN has tripled our GMP production capacity, enabling us to produce clinical materials faster and more efficiently. This expansion is crucial for advancing our pipeline programs and supporting the needs of our partners.

Innovative Solutions: The combination of Eleva’s moss-based platform with 3PBIOVIAN’s manufacturing expertise opens up new possibilities for the development of biologics. This synergy allows us to offer innovative solutions that were previously unattainable.

Accelerated Time to Market: By leveraging the strengths of both companies, we can accelerate the clinical development process and bring new therapies to market more quickly. This partnership enhances our ability to meet the evolving needs of biopharmaceutical developers.